Pfizer, BioNTech submits data seeking FDA approval for its COVID-19 vaccine in children ages 5-11

Rockland-based Pfizer and BioNTech submitted data to the Food and Drug Administration Tuesday on their COVID-19 vaccine trials in children ages 5-11.

More Stories

00:22

Cold Spring Village Hall closed due to COVID-19 surge and staff shortages

Hometown Heroes in the Hudson Valley

Hometown Heroes in New York City

00:33

US Supreme Court rejects appeal on Rutgers University COVID-19 vaccine mandate case

Hometown Heroes in Connecticut

01:28

Medical experts recommend to still take precautions following CDC's revised COVID isolation guidelines